drug
NV-101
Preclinicalupdated 3mo agoby Oncology Pharma Inc
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying NV-101
- phase2A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
- phase2A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
- phase1Single Ascending Dose, Multiple Ascending Dose, Food Effect Study
- phase1Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of INV-101 in Healthy Male and Female Subjects
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that